News | December 26, 2023
AstraZeneca to acquire China's Gracell Biotechnologies for US $1.2 billion
Furthering cell therapy ambition across oncology and autoimmune diseases
Furthering cell therapy ambition across oncology and autoimmune diseases
Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
The company has reported total income of Rs. 135.87 crores during the period ended June 30, 2023
Under the terms of the collaboration, Vertex and Lonza will partner in the process development and scale-up for the manufacturing of the product portfolio and co-invest to build a dedicated new facility in Portsmouth, New Hampshire (US)
Urges Innovators to produce quality products that can be deployed at scale
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
The company has reported total income of Rs. 149.78 crores during the period ended March 31, 2023
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
Subscribe To Our Newsletter & Stay Updated
